FDA-Approved Drug Makes Established Cancer Vaccine Work Better Newswise (press release) The team proposed that daclizumab, already used for kidney transplantation, would be effective in depleting regulatory T cells (Tregs) and restoring the immune system's ability to fight tumors. Tregs are an important population of white blood cells ... |
